HEK293-F Cells
€430.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | HEK293-F cells are a fast-growing, highly transfectable subline derived from the human embryonic kidney 293 (HEK293) cell line. The 'F' designation indicates that these cells have been adapted for growth in suspension cultures, making them particularly useful for large-scale protein production. The cells grow in a variety of serum-free media, facilitating scalable processes in biotechnological and pharmaceutical applications. HEK293-F cells retain the epithelial-like morphology of the parent HEK293 line and are maintained in suspension without the need for attachment to a solid substrate. These cells are highly efficient at expressing recombinant proteins and are widely utilized in the production of viral vectors for gene therapy, including adenoviral, lentiviral, and retroviral vectors. Their robust growth in suspension and ease of transfection make them ideal for use in transient transfection protocols, where they can produce high yields of protein within a few days post-transfection. This characteristic is critical for rapid production cycles in research and industrial settings. The adaptability of HEK293-F cells to various growth conditions and their capacity for high-density culture enhance their utility in bioprocessing environments. |
|---|---|
| Organism | Human |
| Tissue | Kidney |
| Applications | Transfection host |
| Synonyms | HEK-293-F, HEK 293-F, HEK-293F, HEK293F, 293-F, 293 F, 293F |
Characteristics
| Age | Fetus |
|---|---|
| Gender | Female |
| Morphology | Epithelial-like |
| Growth properties | Suspension |
Regulatory Data
| Citation | HEK293-F (Cytion catalog number 300260) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_6642 |
| GMO Status | GMO-S1: This HEK293-F cell line contains SV40 Large T Antigen sequences, enabling high transfection efficiency and robust growth in suspension culture. The modification is stably present in embryonic kidney cells. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Receptors expressed | Vitronectin |
|---|---|
| Protein expression | CEA negative, p53 positive |
| Tumorigenic | In nude mice |
| Viruses | Transformed with adenovirus 5 DNA adenovirus 5 DNA |
Handling
| Culture Medium | CD293 (Thermo) |
|---|---|
| Dissociation Reagent | Accutase |
| Doubling time | 30 hours |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 x 104 cells/cm2 will yield in a confluent layer in about 4 days |
| Fluid renewal | 2 times per week |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300260-170225SF | Certificate of Analysis | 23. May. 2025 | 300260 |
Material Transfer Agreement
If you intend to use Cytion cell lines solely for internal research at a single research site, please complete and sign our Material Transfer Agreement (MTA) and submit it along with your order.
For any commercial applications - including but not limited to fee-for-service work, quality control testing, product release, diagnostic use, or regulatory studies - please complete the Intended Use Form so we can prepare a suitable agreement tailored to your project.
Please note: The MTA applies only to certain cell lines. If this notice and the MTA document appear on a product page, the agreement is applicable. For cell lines not covered by the MTA, no reference to the agreement will be shown. The MTA is not valid for customers in the Americas, China, or Taiwan. Please contact our U.S. entity to receive the appropriate agreement.